Effect of Abdominal Binder aftEr Laparoscopic Treatment on Postoperative Recovery
BELT
1 other identifier
interventional
66
1 country
1
Brief Summary
There have been no studies exploring the efficacy of incision support using an elastic abdominal binder after laparoscopy to date. The investigators performed therefore a randomized controlled trial to determine the effect of post-laparoscopic abdominal binder use on enhanced recovery after surgery (ERAS) in patients with gynecologic disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2018
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 20, 2018
CompletedFirst Posted
Study publicly available on registry
April 2, 2018
CompletedStudy Start
First participant enrolled
April 20, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 5, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
October 31, 2018
CompletedApril 3, 2019
April 1, 2019
4 months
March 20, 2018
April 1, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
postoperative pain
Subjects rated postoperative pain intensity using a visual analog scale (VAS) at 12, 24, and 48 hours after surgery. The scale was presented as a 10-cm line with verbal descriptors ranging from "no pain" to "worst imaginable pain".
at 48 hours after surgery
Secondary Outcomes (2)
limitation of walking ability
at 48 hours after surgery
Incentive spirometry performance
at 24 hours after surgery
Study Arms (2)
Experimental group
EXPERIMENTALIn subjects allocated to the abdominal binder group, the abdomen binder with a standard height of 22 cm (Sejung Korea, Seoul, Republic of Korea) was applied before leaving the operating room. The binder was placed on the abdomen across the laparoscopic incision, with the upper border not higher than the lower margin of the rib cage, ensuring minimal restriction of lateral costal expansion and diaphragmatic excursion. Subjects were carefully instructed to use the abdominal binder during at least the first 2 consecutive days and night, and to reposition the abdominal binder correctly when needed.
Control group
PLACEBO COMPARATORIn subjects allocated in the control group, subjects were not given any opportunity to ware an abdominal binder.
Interventions
In subjects allocated to the abdominal binder group, the abdomen binder with a standard height of 22 cm (Sejung Korea, Seoul, Republic of Korea) was applied before leaving the operating room. The binder was placed on the abdomen across the laparoscopic incision, with the upper border not higher than the lower margin of the rib cage, ensuring minimal restriction of lateral costal expansion and diaphragmatic excursion. Subjects were carefully instructed to use the abdominal binder during at least the first 2 consecutive days and night, and to reposition the abdominal binder correctly when needed.
In subjects allocated in the control group, subjects were not given any opportunity to ware an abdominal binder.
Eligibility Criteria
You may qualify if:
- age between 18 and 65 years
- American Society of Anesthesiologists physical status (ASAPS) classification I-II
- absence of pregnancy at the time of surgery
You may not qualify if:
- body mass index (BMI) ≥30 kg/m2
- history of abdominal surgery within 6 months
- history of ventral or incisional hernia
- walking disabilities (or walking with the assistance of crutches or a walker)
- chronic obstructive respiratory disease
- stage IV cancer,
- chronic pain syndrome (defined as daily intake of opioids for chronic back pain, chronic headache, or fibromyalgia)
- inability to fill out the questionnaire
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kangbuk Samsung Hospital
Seoul, Jongno-gu, 03181, South Korea
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Taejong Song, MD PhD
Kangbuk Samsung Hospital, Seoul, Republic of Korea
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
March 20, 2018
First Posted
April 2, 2018
Study Start
April 20, 2018
Primary Completion
August 5, 2018
Study Completion
October 31, 2018
Last Updated
April 3, 2019
Record last verified: 2019-04
Data Sharing
- IPD Sharing
- Will not share